NCT04030247View on ClinicalTrials.gov

Impact of Plant Sterol Supplement on LDL-C Lowering in Low-to-Moderate Risk South Asian Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Cardiovascular Risk Factor
Interventions
DRUG

Plant Sterol

Patients will receive a plant sterol supplement to take twice daily from their cardiologist/dietician in management of their moderate risk of cardiovascular disease.

Trial Locations (1)

94305

Stanford University, Stanford

Sponsors

Collaborators (1)

Piper Biosciences, Inc.
All Listed Sponsors
collaborator

Piper Biosciences, Inc.

INDUSTRY

lead

Stanford University

OTHER